Priser
Platform
Blog
Om os
Download
3164
Genmont Biotech
Taiwan Stock Exchange
0

Om

Genmont Biotech Inc. is a biotechnology company focused on developing, producing, and distributing probiotic products aimed at promoting health and wellness. Its primary function is to leverage cutting-edge research and technology in the field of microbiology to create effective probiotic solutions. The company’s offerings cater to a diverse range of applications, from dietary supplements to functional foods, targeting both individual consumers and various industries, including nutraceuticals and pharmaceuticals. Genmont Biotech Inc. plays a pivotal role in the global wellness market by continually advancing the understanding of probiotics' benefits. Established as a leader in its field, the company is recognized for its commitment to quality and innovation, often collaborating with academic institutions for research and development. As health and wellness trends gain momentum worldwide, Genmont Biotech Inc. positions itself at the forefront of contributing to the evolving landscape of consumer health products.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GENMONT BIOTECH MED ENDAVU: Køb Genmont Biotech ($3164) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Genmont Biotech, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker3164
Land
Taiwan
Hjemmesidegenmont.com.tw
SektorSundhed
IndustriBioteknologi

Udbytter

0,7TWD
'21
1,1TWD
'22
0,7TWD
'23
0,5TWD
'24
0,8TWD
'25
0,8TWD
'26
Ex-udbytte-dato8. apr. 2026
Udbytteafkast4,52%